From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Reader Remarks

Reader Remarks on:

Bupropion plus Naltrexone for Weight Loss?

Bupropion/Naltrexone study drop-out rate

Anthony K. Rice, Martinsburg WV, 3 Sep 2010 12:20 PM EST

Competing interests: None declared

The participant withdrawal rate seems high. I wonder if this was a result of some unmentioned factor in the study design or population. It doesn't seem to be related to the study medication, since the rate in the placebo arm was similar.

Also, the loss of half the study subjects must negatively impact the power of the study to detect less common adverse effects, even though it was apparently still adequately powered to show a significant weight loss benefit over placebo.

back to top

Bupropion/Naltrexone study drop-out rate

Rachel G Sagar, 27 Sep 2010 11:36 PM EST

Competing interests: None declared

Maybe the ones who were feeling really ill from side effects withdrew! Why else would you withdraw from a study?

back to top

Withdraw maybe disease specific

Rogerio L Coelho, Family Practice - Curitiba Municipal Health System - Brasil, 2 Oct 2010 3:50 PM EST

Competing interests: None declared

Why indeed? And why do people quit tehir diets? And why do peple stop their excercise? And why do people let their weight go astray and cannot even get out of bed?

The Obesity pandemic is a multifactoral, psico-social-genetic phenomenon, it is obvious that obese overeat (the weight keeps on adding) and they continue to do so.

Anyone who treats these patients knows that even the best combination of drugs / diets / excercise will have a major dropout ... what we need is to know WHY this happens, and if we can do anything about it.

back to top

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?



Copyright © 2012. Massachusetts Medical Society. All rights reserved.